Skip to product information
1 of 1

FDA ANDA 215808, KETAMINE HYDROCHLORIDE, FRESENIUS KABI USA, 01/13/2023

FDA ANDA 215808, KETAMINE HYDROCHLORIDE, FRESENIUS KABI USA, 01/13/2023

Regular price $116.95 USD
Regular price Sale price $116.95 USD
Sale Sold out

Contents: Approval letter and summary basis of approval

ANDA: 215808
Company: FRESENIUS KABI USA
Drug Name: KETAMINE HYDROCHLORIDE
Active Ingredients: KETAMINE HYDROCHLORIDE
Strength: EQ 50MG BASE/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 01/13/2023
Marketing Status: Prescription
Submission Classification: ORIG-1

23 Pages

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome